Why Rx/Dx Social Media is About the Patient and Not the Drug/Device

Via the WSJ Novartis gets dinged by the FDA.

This is why strategically, Rx/Dx companies should focus on the patient and be about providing valuable info about the disease rather than promote a product.

Social media is not about the company or the brand, its about interaction, in a valuable way to people. It's the right thing to do.

In the least, what we learned from the FDA hearings last fall is that you should proactively put risk info 1-click away.

Unfortunately for Novartis it's another lesson for everyone else, however I am glad to see the FDA paying attention. And by the looks of things they be paying even closer attention in the future with some of their recent hirings.







| www.jlefevere.com | www.thedigitalstrategist.com | If you liked this post consider adding a comment or subscribing to the feed for frequent updates.
  • Digg
  • del.icio.us
  • StumbleUpon
  • Yahoo! Buzz
  • Technorati
  • Facebook
  • TwitThis
  • MySpace
  • LinkedIn
  • Live
  • Google
  • Reddit
  • Sphinn
  • Propeller
  • Slashdot
  • Netvibes

0 comments: